Label on hormone products to reflect concern of risks

Friday, September 6, 2002

The maker of the most popular hormone therapies for post-menopausal women has told doctors that there are possibly increased risks from all its estrogen-based products, and that their labels will now reflect that concern.

To continue reading
For more than 115 years, the Southeast Missourian has written the first draft of local history. We have aspired to enrich, entertain, educate and inform. Our core values have remained firm: truth, service, quality, integrity and community. Support our mission.